Condition: Breast Neoplasms · Sponsor: SKIA Inc.
This clinical trial aims to evaluate whether an augmented reality (AR)-based medical imaging solution (SKIA-Breast) is non-inferior to conventional ultrasound-guided skin marking in guiding breast-conserving surgery in female patients with breast cancer. Participants will be randomly assigned in a 1:1 ratio to either the AR-based group or the conventional group. All participants will undergo breast-conserving surgery according to their assigned method. The primary outcome is the negative margin resection rate evaluated by histopathological examination. The secondary outcome is the re-excision rate due to positive margins assessed by histopathological examination.
This description comes directly from the study's public registry record.
Jeongmi LEE · +821048856620 · jmlee@skia.kr
Always discuss trial participation with your own doctor first.
| Ewha Womans University Medical Center | Seoul, Gangseo-gu, South Korea | Recruiting |
| Seoul National University Hospital | Seoul, Jongno-gu, South Korea | Recruiting |
| Yonsei University Health System, Severance Hospital | Seoul, Seodaemun-gu, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07003841